Literature DB >> 8524305

Unliganded thyroid hormone receptor alpha can target TATA-binding protein for transcriptional repression.

J D Fondell1, F Brunel, K Hisatake, R G Roeder.   

Abstract

Unliganded human thyroid hormone receptor alpha (hTR alpha) can repress transcription by inhibiting the formation of a functional preinitiation complex (PIC) on promoters bearing thyroid hormone receptor (TR)-binding elements. Here we demonstrate that hTR alpha directly contacts the TATA-binding protein (TBP) and that preincubation of hTR alpha with TBP completely alleviates TR-mediated repression in vitro. Using stepwise preassembled PICs, we show that hTR alpha targets either the TBP/TFIIA or the TBP/TFIIA/TFIIB steps of PIC assembly for repression. We also show that the repression domain of hTR alpha maps to the C-terminal ligand-binding region and that direct TR-TBP interactions can be inhibited by thyroid hormone. Together, these results suggest a model in which unliganded hTR alpha contacts promoter-bound TBP and interferes with later steps in the initiation of transcription.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8524305      PMCID: PMC231001          DOI: 10.1128/MCB.16.1.281

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

1.  Definition of the transcriptional activation domain of recombinant 43-kilodalton USF.

Authors:  B J Kirschbaum; P Pognonec; R G Roeder
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

Review 2.  Advances in RNA polymerase II transcription.

Authors:  L Zawel; D Reinberg
Journal:  Curr Opin Cell Biol       Date:  1992-06       Impact factor: 8.382

3.  Purification of his-tagged proteins in non-denaturing conditions suggests a convenient method for protein interaction studies.

Authors:  A Hoffmann; R G Roeder
Journal:  Nucleic Acids Res       Date:  1991-11-25       Impact factor: 16.971

Review 4.  The complexities of eukaryotic transcription initiation: regulation of preinitiation complex assembly.

Authors:  R G Roeder
Journal:  Trends Biochem Sci       Date:  1991-11       Impact factor: 13.807

5.  Expression and purification of general transcription factors by FLAG epitope-tagging and peptide elution.

Authors:  C M Chiang; R G Roeder
Journal:  Pept Res       Date:  1993 Mar-Apr

6.  Structural motifs and potential sigma homologies in the large subunit of human general transcription factor TFIIE.

Authors:  Y Ohkuma; H Sumimoto; A Hoffmann; S Shimasaki; M Horikoshi; R G Roeder
Journal:  Nature       Date:  1991-12-05       Impact factor: 49.962

7.  Holo-TFIID supports transcriptional stimulation by diverse activators and from a TATA-less promoter.

Authors:  Q Zhou; P M Lieberman; T G Boyer; A J Berk
Journal:  Genes Dev       Date:  1992-10       Impact factor: 11.361

8.  Wild-type p53 binds to the TATA-binding protein and represses transcription.

Authors:  E Seto; A Usheva; G P Zambetti; J Momand; N Horikoshi; R Weinmann; A J Levine; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

9.  A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor.

Authors:  A Baniahmad; A C Köhne; R Renkawitz
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

10.  Human transcription factor USF stimulates transcription through the initiator elements of the HIV-1 and the Ad-ML promoters.

Authors:  H Du; A L Roy; R G Roeder
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

View more
  44 in total

1.  In vivo transcription factor recruitment during thyroid hormone receptor-mediated activation.

Authors:  M K Kim; J S Lee; J H Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

2.  p300 requires its histone acetyltransferase activity and SRC-1 interaction domain to facilitate thyroid hormone receptor activation in chromatin.

Authors:  J Li; B W O'Malley; J Wong
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

3.  Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily.

Authors:  U Dressel; D Thormeyer; B Altincicek; A Paululat; M Eggert; S Schneider; S P Tenbaum; R Renkawitz; A Baniahmad
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

4.  Domain structure of the NRIF3 family of coregulators suggests potential dual roles in transcriptional regulation.

Authors:  D Li; F Wang; H H Samuels
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

5.  Alleviation of human papillomavirus E2-mediated transcriptional repression via formation of a TATA binding protein (or TFIID)-TFIIB-RNA polymerase II-TFIIF preinitiation complex.

Authors:  S Y Hou; S Y Wu; T Zhou; M C Thomas; C M Chiang
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

6.  Repression of the luteinizing hormone receptor gene promoter by cross talk among EAR3/COUP-TFI, Sp1/Sp3, and TFIIB.

Authors:  Ying Zhang; Maria L Dufau
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

7.  Transcriptional repression by the SMRT-mSin3 corepressor: multiple interactions, multiple mechanisms, and a potential role for TFIIB.

Authors:  C W Wong; M L Privalsky
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

8.  Mad proteins contain a dominant transcription repression domain.

Authors:  D E Ayer; C D Laherty; Q A Lawrence; A P Armstrong; R N Eisenman
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

9.  The histone acetylase PCAF is a nuclear receptor coactivator.

Authors:  J C Blanco; S Minucci; J Lu; X J Yang; K K Walker; H Chen; R M Evans; Y Nakatani; K Ozato
Journal:  Genes Dev       Date:  1998-06-01       Impact factor: 11.361

Review 10.  Molecular aspects of thyroid hormone actions.

Authors:  Sheue-Yann Cheng; Jack L Leonard; Paul J Davis
Journal:  Endocr Rev       Date:  2010-01-05       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.